Interestingly, recent studies produced evidence in favour of a natural protection against AD in human carriers of the A2T Aβ mutation29, another human Aβ variant characterized by an alanine-to-threonine substitution at the same APP codon of the A2V-Aβ mutation (APP-A673T or AβA2T variant). The gene discussed is APP; the disease is Alzheimer disease.